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INHIBITORY EFFECT OF DEFEROXAMINE ON Paracoccidioides brasiliensis SURVIVAL IN
HUMAN MONOCYTES: REVERSAL BY HOLOTRANSFERRIN NOT BY APOTRANSFERRIN
Luciane Alarcão DIAS-MELICIO(1), Sueli Aparecida CALVI(2), Maria Terezinha Serrão PERAÇOLI(1) & Ângela Maria Victoriano de Campos SOARES(1)
SUMMARY
The mechanisms used by Paracoccidioides brasiliensis to survive into phagocytic cells are not clear. Cellular iron metabolism
is of critical importance to the growth of several intracellular pathogens whose capacity to multiply in mononuclear phagocytes is
dependent on the availability of intracellular iron. Thus, the objective of this paper was to investigate the role of intracellular iron
in regulating the capacity of P. brasiliensis yeast cells to survive within human monocytes. Treatment of monocytes with
deferoxamine, an iron chelator, suppressed the survival of yeasts in a concentration-dependent manner. The effect of deferoxamine
was reversed by iron-saturated transferrin (holotransferrin) but not by nonsaturated transferrin (apotransferrin). These results
strongly suggest that P. brasiliensis survival in human monocytes is iron dependent.
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INTRODUCTION
Paracoccidioidomycosis is a deep mycosis that is endemic in Latin
America. This disease is caused by Paracoccidioides brasiliensis, a
fungus that undergoes thermal dimorphism, developing as yeast at body
temperature and as a mycelium at room temperature5. This fungus
causes natural infections by inhalation of conidia or mycelial elements.
These conidia convert to the parasitic yeast form in the lungs of mice12.
Ingest conidia or yeast-forms of P. brasiliensis readily multiplies inside
murine alveolar or peritoneal macrophages; however if they were
activated by cytokines, such as IFN-γ, the multiplication was limited
and conidia or yeast cells were killed2,4. Similarly, the interaction of
human phagocytic cells and yeast-form of P. brasiliensis was studied
in vitro. Yeast cells were readily ingested by monocytes or monocyte-
derived macrophages. However, these cells allow P. brasiliensis
multiplication, unless they were activated with IFN-γ or culture
supernatants from concanavalin-A-stimulated mononuclear cells13. The
mechanisms used by P. brasiliensis yeasts to survive and to multiply
within human monocytes or macrophages are poorly understood. Iron
has been considered an essential element for microbial growth and has
also been associated with microorganisms’ virulence by promoting
intracellular growth10. Moreover, studies showed that both mycelial
and yeast forms of P. brasiliensis have metabolic requirement for iron,
which is shown in the ability of both forms to grow in the presence of
low concentrations of iron1. In this study we have explored the role of
iron in the intracellular growth or survival of P. brasiliensis in
nonactivated human monocytes. We shall show that P. brasiliensis
intracellular survival is iron dependent since this process is inhibited
by iron chelator deferoxamine. Besides, the inhibition of deferoxamine
is reverted by holotransferrin, an iron-saturated transferrin.
MATERIALS AND METHODS
1. Donors: We studied monocytes from healthy blood volunteer’s
donors, with informed consent from the University Hospital of the
Botucatu Medical School, São Paulo State University (Brazil). This
study was approved by the Ethics Committee of the Hospital.
2. Isolation of peripheral blood mononuclear cells: Peripheral
blood mononuclear cells (PBMC) were isolated from heparinized
venous blood by density gradient centrifugation at 300 × g for 30 min
on Histopaque (d = 1.077) (Sigma Chemical Co., St. Louis, Mo.).
Briefly, 10 mL of heparinized blood was mixed with an equal volume
of complete tissue culture medium (CTCM) which consisted of RPMI
1640 tissue culture medium that does not contain iron (Sigma Chemical
Co, St Louis, Mo), supplemented with 2 mM L-glutamine, 10% heat-
inactivated human AB serum, 20 mM HEPES and 40 µg/mL gentamicin
(Gibco Laboratories, Grand Island, N.Y.). Samples were layered over
5 mL of Histopaque in a 15 mL conical plastic centrifuge tube. After
centrifugation at 300 × g for 30 min at room temperature, the interface
layer of PBMC was harvested and washed twice with PBS-EDTA and
once with CTCM. The counting of the monocytes were made with
neutral red (0.02%) staining and the mononuclear cells were suspended
to 2 × 106 monocytes/mL in CTCM.
3. Monocyte monolayers: The PBMC suspension, containing
2 × 106 monocytes/mL, was dispensed into 100 µL/wells in 96-well
flat-bottomed plates (Nunc, Life Tech. Inc., Maryland, USA). After
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incubation for two h at 37 °C in 5% CO2, nonadherent cells were
removed by aspiration and each well was rinsed twice with CTCM.
After adherence, the monocytes were cultured in CTCM at 37 °C in
5% CO2 for 24 h, alone or containing the following treatments: a)
deferoxamine (15, 25 and 35 µM), b) deferoxamine (35 µM) plus
holotransferrin (3 and 6 µg/mL), c) deferoxamine (35 µM) plus
apotransferrin (3 and 6 mg/mL). All these drugs were obtained from
the Sigma Chemical Co. (St Louis, Mo).
 4. Fungi: P. brasiliensis strain 18 (Pb 18) was maintained in the
yeast-form cells at 35 °C on 2% Glucose, 1% Peptone, 0.5% Yeast
extract and 2% agar medium (GPY medium) for six days. Yeast viability
was determined by phase contrast microscopy and bright yeast cells
were counted as viable, while dark ones were considered not viable.
Fungal suspensions containing more than 90% viable cells were used
in the experiments.
5. Challenge of monocyte cultures with P. brasiliensis for
evaluation of viable fungi recovery percentage: After removal of
the supernatants from control (no treated) and treated monolayers, the
viable fungus recovery of monocytes was tested by challenging with 2
× 104 viable yeasts/mL of Pb 18 (ratio 100 monocytes: 1 fungus)
prepared with CTCM containing 10% fresh human AB serum, as source
of complement for yeast opsonization. The control of phagocytosis
was made by plating the supernatants of cocultures. After coculture
for 18 h, cells were harvested by aspiration with sterile distilled water
to lyse monocytes. Each culture well washing was contained in a final
volume of 1 mL. The number of colony forming units (CFU) of P.
brasiliensis in the cultures was determined by plating 100 µL of the 1
mL harvested volume on to brain-heart infusion agar medium (Difco
Laboratories, Detroit, MI, USA) containing 4% normal horse serum
and 5% P. brasiliensis strain 192 culture filtrate (v/v), the latter being
the source of growth-promoting factor16. A well containing only 100 µL
of P. brasiliensis yeast-form (2 × 104 viable units/mL) was also
incubated using the same procedures for the monocyte cultures
challenged with P. brasiliensis, to establish the calculation of viable
fungi recovery percentage. Inoculated plates were incubated at 35 °C
in sealed plastic bags to prevent drying. After 10 days the number of
colony forming units (CFU) in each plate was counted. The percentage
of viable fungus recovery was determined by the formula:
6. Statistical analysis: Data were statistically analyzed using the
Sigma Stat 2.0 statistical software (Jandel Corporation). The results
were compared by Friedman Test, with the level of significance set at
p < 0.05.
RESULTS
Deferoxamine inhibits the intracellular survival of P. brasiliensis
in human monocytes: In initial experiments we tested the effect of
different concentrations of deferoxamine in the survival of P.
brasiliensis within human monocytes. Monocyte monolayers were
cultured for 24 h at 37 °C in the presence of three concentrations of
deferoxamine (15, 25 and 35 µM) and after challenged with 2 × 103
yeasts. The recovery of viable fungi was detected by cocultures plating
and counting of colony forming units (CFU) as described in Materials
and Methods. Deferoxamine significantly inhibited the survival of the
fungus within monocytes in the concentration of 35 µM (Fig. 1). The
viability of control and deferoxamine-treated monocytes was > 95%
as determined by trypan blue dye exclusion.
 Holotransferrin reverses deferoxamine inhibition of
intracellular survival of P. brasiliensis yeasts: To demonstrate that
deferoxamine suppressed the intracellular survival of Pb18 yeasts by
chelating iron from cells, human monocyte monolayers were cultured
for 24 h at 37 °C in CTCM or in the presence of 35 µM of deferoxamine
alone or with deferoxamine plus holotransferrin at 3 and 6 mg/mL.
After, the cultures were challenged during 18 h with 2 × 103 yeasts of
P. brasiliensis. The viable fungi recovery was detected by cocultures
plating and colony forming units counting (CFU). Holotransferrin at 6
mg/mL, that replaced intracellular iron, completely reversed the
inhibition of yeast survival by deferoxamine, and holotransferrin at 3
mg/mL partially reversed the effect of the chelator (Fig. 2).
Apotransferrin does not reverse deferoxamine inhibition of
intracellular survival of P. brasiliensis yeasts: The monolayer treatment
with deferoxamine plus apotransferrin (iron nonsaturated transferrin) at
3 and 6 mg/mL did not reverse the deferoxamine effect on the Pb18
survival, showing that the effect was not transferrin dependent, and the
inhibition caused by deferoxamine on the survival of Pb18 in monocytes
was really caused by chelate iron from the cell (Fig. 3).
DISCUSSION
Our study demonstrated that deferoxamine inhibits the intracellular
survival of P. brasiliensis in human monocytes by interfering in the
Fig. 1 - Deferoxamine inhibits the survival of P. brasiliensis yeasts in human monocytes in a
concentration of 35 µM. Monocyte cultures were preincubated with deferoxamine at 15, 25
and 35 µM during 24 h and after challenged with 2 x 103 yeasts of P. brasiliensis during 18
h. The cocultures were plated and after 10 days the colony forming units (CFU) were counted.
A culture containing only P. brasiliensis was also plated in the same conditions and the
viable fungi recovery % was calculated. Box-and-whisker plot showing data distribution of
12 individuals. Horizontal lines represent the median values, boxes represent the 25th to 75th
percentiles and vertical lines the 10th to 90th percentiles. * Statistical significance between
groups is indicated - Control versus Def 35 (p < 0.05).
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iron acquisition, reinforcing the hypothesis that the availability of
intracellular iron is clearly required for the survival of P. brasiliensis
yeast cells in human phagocytic cells. The role of iron in the process
above is based upon the experiments showing that during infections a
decrease in serum free iron associated with an increase of serum
transferrin and lactoferrin occur14,18,19,20. Thus, iron is accumulated in
spleen and liver macrophages by inhibition of its release from these
cells, preventing its normal recycling to transferrin21. Concomitantly,
macrophages initiate the ferritin synthesis that enables these cells to
acquire iron from ingested erythrocytes. Paradoxically, this response
to infection may enhance the pathogenicity of intracellular
microorganisms such as P. brasiliensis, by providing them sufficient
amount of iron, which is important for their survival or multiplication
inside these cells.
Although we did not analyze the influence of deferoxamine in the
phagocytic indices, due to the difficulties in standardizing this type of
assay with P. brasiliensis yeast cells, we plated all coculture
supernatants in order to verify if there were free yeasts in the culture.
We did not recover significant amounts of CFU in these plates showing
that our opsonization system using fresh AB human serum was effective.
These results allow us to consider that the deferoxamine effect on the
yeast survival decrease was not due to impairment of phagocytosis.
Besides, other authors verified that deferoxamine did not influence
phagocytosis of opsonized sheep erythrocytes and the microscopic
inspection failed to show any significant morphological differences
between deferoxamine-treated and no treated cells11.
In our assays, we observed a reduction of P. brasiliensis survival
after deferoxamine treatment. This finding may be explained because
this drug, under physiologic conditions, does not chelate a significant
amount of iron bound to transferrin15, and does not remove it from
ferritin8. Thus, deferoxamine chelates only the free iron pool, suggesting
that P. brasiliensis takes it from the intracellular pool, what can be
used by the cell or by microorganisms. In the present study, P.
brasiliensis survival inhibition was reversed by holotransferrin, which,
in turn, could supply sufficient iron, and then, revert deferoxamine
effects. This result was expected seeing that holotransferrin contains
two molecules of ferric iron, and when it binds to the transferrin
receptor, this complex is endocytosed. Within the cell, the endocytic
vacuole is acidified, and transferrin releases ferric ions, which is
incorporated to the available iron pool, used by the cell or
microorganisms7,17. Our result with apotransferrin plus deferoxamine
treatment showed that the effects were not mediated by transferrin.
The modulation of intracellular iron pool by deferoxamine has been
studied in the interaction of other microorganisms with phagocytic
cells. The treatment of phagocytic cells with deferoxamine inhibited
H. capsulatum9, T. cruzi11 and L. pneumophila3 replication. This same
effect was seen preincubating these cells with IFN-γ, which reduced
transferrin receptors expression, and also limited the available
intracellular iron3,9. The effect of deferoxamine and IFN-γ was reversed
by simultaneous incubation with holotransferrin, which replaced
intracellular iron. On the contrary, L. pneumophila growth increased
in tioglicolate-stimulated murine peritoneal macrophages, and this
process was associated with higher transferrin receptor expression and
increased free intracellular iron. Either apotransferrin or deferoxamine
inhibited this intracellular growth by down regulating the intracellular
iron pool, being reversed by holotransferrin or FENTA (ferric
nitrilotriacetate)6.
Fig. 2 - Holotransferrin completely reverses deferoxamine (35 µM) inhibition on the survival
of Pb yeasts in human monocytes in a concentration of 6 mg/mL. Monocyte cultures were
preincubated with deferoxamine plus holotransferrin (3 and 6 mg/mL) during 24 h and after
challenged with 2 x 103 yeasts of P. brasiliensis during 18 h. The cocultures were plated and
after 10 days the colony forming units (CFU) were counted. A culture containing only P.
brasiliensis was also plated in the same conditions and the viable fungi recovery % was
calculated. Box-and-whisker plot showing the median values of 12 individuals. Horizontal
lines represent the median values, boxes represent the 25th to 75th percentiles and vertical
lines the 10th to 90th percentiles. * Control versus Def 35 (p < 0.05); * Control versus Def
35+Holo3 (p < 0.05); # Def 35 versus Def 35+Holo6 (p < 0.05).
Fig. 3 - Apotransferrin does not reverse deferoxamine (35 µM) inhibition on the survival of
Pb yeasts in human monocyte. Monocyte cultures were preincubated with deferoxamine
plus apotransferrin (3 and 6 mg/mL) during 24 h and after challenged with 2 x 103 yeasts of
P. brasiliensis during 18 h. The cocultures were plated and after 10 days the colony forming
units (CFU) were counted. A culture containing only P. brasiliensis was also plated in the
same conditions and the viable fungi recovery % was calculated. Box-and-whisker plot
showing the median values of 12 individuals. Horizontal lines represent the median values,
boxes represent the 25th to 75th percentiles and vertical lines the 10th to 90th percentiles. *
Control versus Def 35 (p < 0.05); * Control versus Def 35+Apo3 (p < 0.05); * Control
versus Def 35+Apo6 (p < 0.05).
266
DIAS-MELICIO, L.A.; CALVI, S.A.; PERAÇOLI, M.T.S. & SOARES, A.M.V.C. - Inhibitory effect of deferoxamine on Paracoccidioides brasiliensis survival in human monocytes: reversal
by holotransferrin not by apotransferrin. Rev. Inst. Med. trop. S. Paulo, 47(5): 263-266, 2005.
In conclusion, our study strongly supports the hypothesis that P.
brasiliensis survival in human monocytes is iron dependant. As
mentioned, several studies demonstrated that the phagocytic activation
process, mainly the one that is IFN-γ dependant, inhibits transferrin
receptor expression with consequent reduction of the iron pool labile.
Thus, in paracoccidioidomycosis patients, alterations in cytokines
levels, that could either interfere in the transferrin receptor or other
mechanisms involved in iron availability, could favor P. brasiliensis
survival or growth in phagocytic cells patients. Future investigations
may better elucidate these mechanisms.
RESUMO
Efeito inibidor da deferoxamina sobre a sobrevivência do
Paracoccidioides brasiliensis em monócitos humanos: reversão
por holotransferrina e não por apotransferrina
Os mecanismos utilizados pelo Paracoccidioides brasiliensis para
sobreviver em células fagocitárias ainda não estão elucidados. O
metabolismo celular férrico é muito importante para o crescimento de
inúmeros patógenos intracelulares cuja capacidade de se multiplicarem
em fagócitos mononucleares é dependente da disponibilidade
intracelular do íon ferro. Assim, o objetivo deste trabalho foi investigar
o papel do ferro intracelular sobre a capacidade do P. brasiliensis
sobreviver em monócitos humanos. O tratamento de monócitos com
deferoxamina, uma droga quelante, diminuiu a sobrevivência de
leveduras do fungo de forma dose-dependente. O efeito inibidor da
deferoxamina sobre a sobrevivência do P. brasiliensis foi revertido
por transferrina saturada com ferro (holotransferrina) mas não por
transferrina insaturada (apotransferrina). Estes resultados sugerem que
a sobrevivência do P. brasiliensis em monócitos humanos é dependente
do íon ferro.
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